In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Levaquin, Tavanic, Levofloxacin Drug Master File in Korea (Levaquin, Tavanic, Levofloxacin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Levaquin, Tavanic, Levofloxacin. The MFDS reviews the Levaquin, Tavanic, Levofloxacin KDMF as part of the drug registration process and uses the information provided in the Levaquin, Tavanic, Levofloxacin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Levaquin, Tavanic, Levofloxacin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Levaquin, Tavanic, Levofloxacin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Levaquin, Tavanic, Levofloxacin suppliers with KDMF on PharmaCompass.